Detalhe da pesquisa
1.
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.
Blood
; 122(8): 1455-63, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23770776
2.
Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis.
J Immunol
; 183(6): 3770-7, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19710474
3.
CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.
Blood
; 112(12): 4683-9, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18216294
4.
Novel antibody-based therapeutic agents targeting CD70: a potential approach for treating Waldenström's macroglobulinemia.
Clin Lymphoma Myeloma
; 9(1): 90-3, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19362984
5.
Preclinical characterization of SGN-70, a humanized antibody directed against CD70.
Clin Cancer Res
; 14(23): 7763-72, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047103
6.
Targeting CD70 for human therapeutic use.
Adv Exp Med Biol
; 647: 108-19, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19760069
7.
Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
Cancer Res
; 65(18): 8331-8, 2005 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16166310
8.
Distinct apoptotic signaling characteristics of the anti-CD40 monoclonal antibody dacetuzumab and rituximab produce enhanced antitumor activity in non-Hodgkin lymphoma.
Clin Cancer Res
; 17(14): 4672-81, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21610152
9.
Clinical binding properties, internalization kinetics, and clinicopathologic activity of brentuximab vedotin: an antibody-drug conjugate for CD30-positive lymphoid neoplasms.
Clin Lymphoma Myeloma Leuk
; 12(4): 280-3, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22542449
10.
Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities.
Blood
; 109(3): 1185-92, 2007 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17038522
11.
Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses.
Cancer Immunol Immunother
; 52(7): 413-22, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12835918